[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@adamfeuerstein](/creator/twitter/adamfeuerstein) "$XLRN This (below) is what Behzad said about Immunomedics before he took control and got it sold to Gilead"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1443666188635099140) 2021-09-30 19:56:56 UTC 119.4K followers, XX engagements "The podcast interview I mentioned earlier: A mothers perspective on Sareptas $SRPT gene therapy halt via @statnews"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948417194670326080) 2025-07-24 16:17:13 UTC 119.4K followers, 18.1K engagements "STAT's @matthewherper talks with $MRK CEO Rob Davis about the $11B $XLRN deal and the pharma giant's "post Keytruda" strategy"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1443606182187384836) 2021-09-30 15:58:29 UTC 119.4K followers, XX engagements "$SRPT The death referred to in the FDA statement may be the boy from Brazil who was disclosed earlier today by Brazilian authorities. Details in that announcement were scant but the timing of that death and age described in the FDA statement fit what STAT had learned about that case. Will let you know if I confirm"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948864978733105494) 2025-07-25 21:56:33 UTC 119.4K followers, 19.2K engagements "Drugmakers are racing to help patients stay awake and could also make billions A great read from my colleague @elaineywchen reporting on the development of orexin inhibitors $ALKS $CNTA $TAK Link below"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947632592309637171) 2025-07-22 12:19:29 UTC 119.4K followers, 9224 engagements "NEW: Sarepta Therapeutics $SRPT crisis is huge blow to Duchenne families company Our attempt to put the past 20-ish insane hours into perspective. via @Jasonmmast and me"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946306897440559372) 2025-07-18 20:31:39 UTC 119.4K followers, 13.8K engagements "$NTLA clinical update: 8K This new Liver tox. In addition enrollment in our global Phase X MAGNITUDE study of nex-z for ATTR-CM is progressing according to our expectations. Currently we have enrolled approximately XXX patients in the MAGNITUDE study out of an expected total enrollment of approximately XXX patients and anticipate enrollment completion by early 2027. Over two hundred patients have been dosed with nex-z in the MAGNITUDE study. To date reported adverse events have been similar in nature to the reported adverse events in the Phase X study of nex-z for ATTR amyloidosis and have"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1927829257234870741) 2025-05-28 20:48:06 UTC 119.4K followers, 40.4K engagements "George Tidmarsh named new CDER chief per Bloomberg"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947245710530732146) 2025-07-21 10:42:10 UTC 119.4K followers, 12.5K engagements "Just in the past week Takeda announced that two late-stage trials succeeded and Alkermes disclosed its mid-stage study was positive saying that its therapy helped patients reach normal levels of wakefulness. Along with Centessa Pharmaceuticals the drugmakers are also testing orexin candidates in narcolepsy type X and idiopathic hypersomnia other sleep conditions that the drugs have shown early potential to treat. In these three rare sleep disorders alone analysts project a greater than $X billion market with potential to grow even bigger as more patients seek diagnoses and treatment"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947632595648360598) 2025-07-22 12:19:30 UTC 119.4K followers, 5115 engagements "$SRPT Its always my fault. Or the medias fault. 🙄 Well folks I didnt cause Sareptas clinical trials to fail. I didnt decide to approve Elevidys for a broad swath of DMD patients. I dont treat patients nor influence whether they benefit or not. Im not responsible for liver failure hospitalizations or deaths. I didnt set Sareptas material disclosure policy. The FDA didnt ask for my advice on whether to ask Sarepta to halt shipments and Sarepta didnt consult with me when it refused. I dont work for Sarepta. I dont work for the FDA. I have no financial ties to Sarepta. No financial disclosures"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946989884218179682) 2025-07-20 17:45:36 UTC 119.4K followers, 61.1K engagements "$SRPT FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys So sad"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948860731610325394) 2025-07-25 21:39:41 UTC 119.4K followers, 45.1K engagements "$SRPT CEO Doug Ingram concludes today's conference call by saying "We are a very transparent organization.""  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946227685128089613) 2025-07-18 15:16:53 UTC 119.3K followers, 25.8K engagements "EXCLUSIVE: Sarepta Therapeutics $SRPT Duchenne therapy faces arduous path back to market senior FDA official says via @Jasonmmast and me"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947727145511620921) 2025-07-22 18:35:13 UTC 119.4K followers, 49.2K engagements "@Sanctuary_Bio @JacobPlieth @ApexOnco $COGT CEO leans too heavily into the $BPMC avi hate. Let the data speak for itself without the passive-aggressive insults. It's counterproductive"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1942296407135653987) 2025-07-07 18:55:24 UTC 119.4K followers, 2242 engagements "$PFE bought a PD1xVEGF antibody from Chinas 3SBio. $1.25B upfront"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1924619787079921967) 2025-05-20 00:14:49 UTC 119.4K followers, 42.1K engagements "$SRPT With Elevidys paused risk to balance sheet and solvency is an issue again. Obviously will depend on how long Elevidys remains off the market and whether Sarepta can restructure debt if necessary"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947461414823841928) 2025-07-22 00:59:18 UTC 119.4K followers, 24.1K engagements "$LLY acquires $ARMO for $1.6B to strengthen cancer immunotherapy pipeline As @bradloncar says It's a cytokine world"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/994550957022285825) 2018-05-10 12:13:20 UTC 119.4K followers, XX engagements "What the f--k is this person talking about"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946992738789884367) 2025-07-20 17:56:56 UTC 119.3K followers, 28.8K engagements "Akeso and $SMMT Ivonescimab in Combination with Chemotherapy Demonstrates Statistically Significant and Strongly Positive Results in First-Line Treatment of Squamous Non-Small Cell Lung Cancer (sq-NSCLC) vs. Tislelizumab in Combination with Chemotherapy"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1914991167441142027) 2025-04-23 10:34:07 UTC 119.3K followers, 15.7K engagements "Alkermes $ALKS drug helped narcolepsy patients stay awake in Phase X trial More orexin results but no numbers for now. via @elaineywchen"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947237601028571284) 2025-07-21 10:09:56 UTC 119.3K followers, 9421 engagements "Constellations myelofibrosis drug shows greater benefit easing concerns about its future #ASH20 $CNST $INCY"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1335649064776577025) 2020-12-06 18:15:26 UTC 119.4K followers, XX engagements "Now official and then some. Sarepta Therapeutics $SRPT lays off one-third of workforce in drastic cost-cutting move w/ @Jasonmmast"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1945579122706599958) 2025-07-16 20:19:44 UTC 119.3K followers, 11K engagements "Sarepta Therapeutics $SRPT the maker of a gene therapy for Duchenne muscular dystrophy that is being temporarily shelved because of safety concerns faces an arduous and treacherous path to try to get it back onto the market a senior official at the Food and Drug Administration told STAT suggesting the treatments license could be revoked"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947727324528476319) 2025-07-22 18:35:55 UTC 119.4K followers, 16.8K engagements "I'm just seeing this now but Joe Schwartz at Leerink is doing hero's work today on $SRPT"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946367772339913053) 2025-07-19 00:33:33 UTC 119.4K followers, 35.7K engagements "The crisis over Sareptas $SRPT Duchenne therapy is a mess. But the lesson is clear via @matthewherper"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947366347723116596) 2025-07-21 18:41:32 UTC 119.4K followers, 9946 engagements "UnitedHealth $UNH confirms DOJ investigations into Medicare practices says its cooperating via @TaraBannow"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948386169655275544) 2025-07-24 14:13:56 UTC 119.4K followers, 7243 engagements "UPDATED:. Sarepta Therapeutics $SRPT crisis is huge blow to Duchenne families company Company has refused FDA request that it pull gene therapy from the market following patient deaths"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946358008436461589) 2025-07-18 23:54:45 UTC 119.4K followers, 48.5K engagements "$CELG would have raised the $ARMO offer to $XX after KN-189"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/999277425174503424) 2018-05-23 13:14:38 UTC 119.4K followers, XX engagements "I made another strawberry rhubarb pie today will be sharing with a friend once it cools down"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948847306326835362) 2025-07-25 20:46:20 UTC 119.4K followers, 8070 engagements "$SRPT More confirmation here from @Jared_Whitlock of what we heard. The patient death occurred one month ago. Let that sink in when you think back to yesterday"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946020282906321311) 2025-07-18 01:32:45 UTC 119.4K followers, 49.6K engagements "Why did $SRPT reverse course Sarepta says this "proactive" step will give it time to confer with FDA and remove Elevidys from its regulatory limbo (meaning hopefully keeping the drug on the market for ambulatory patients.) But Sarepta was also forced into this reversal bc hospitals were pausing use of Elevidys out of caution and safety/liability concerns STAT learned"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947454466707324993) 2025-07-22 00:31:41 UTC 119.3K followers, 8985 engagements "$SRPT FDA will request Sarepta Therapeutics voluntarily stop all shipments of Elevidys - Reuters citing a source familiar with the matter Stock halted"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946254296137228503) 2025-07-18 17:02:38 UTC 119.3K followers, 32.8K engagements "Why Sarepta may not survive its current gene therapy crisis. Plus: Who gets to decide the CEOs fate"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948361333096751402) 2025-07-24 12:35:15 UTC 119.4K followers, 6888 engagements "Cogent Biosciences $COGT drug improves symptoms of chronic immune disorder study results show A comparison of the therapy to a rival treatment from Blueprint Medicines $BPMC remains muddled"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1942236971587223654) 2025-07-07 14:59:13 UTC 119.4K followers, 10.4K engagements "Merck $MRK to buy lung-disease biotech Verona Pharma $VRNA for $XX billion -- $XXX / share XX% premium -- Deal centerpiece: Verona's Ohtuvayre a treatment for chronic obstructive pulmonary disease. Blockbuster in the making. -- Merck needs to replace the expected loss of revenue when blockbuster cancer drug Keytruda loses patent protection. -- 2nd largest M&A transaction this year. -- Pharma has appetite for commercial-stage companies: Verona Intra-Cellular Blueprint"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1942907633389703229) 2025-07-09 11:24:11 UTC 119.4K followers, 19.2K engagements "Small biotech Abivax $ABVX scores major win with ulcerative colitis trials Stock trading +400% to $XX this morning. Incredible via @DrewQJoseph"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947950831896076362) 2025-07-23 09:24:04 UTC 119.4K followers, 12.9K engagements "Regenerons Yancopoulos is still bitter over Praluent sales. Can Novartis do better $REGN $NVS $MDCO #JPM20"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1217481878216667136) 2020-01-15 16:21:14 UTC 119.3K followers, XX engagements "$SRPT Fully updated story w/ Brazil Japan suspensions Elevidys patient death in Brazil said to be due to influenza Europe moves to reject embattled Duchenne muscular dystrophy gene therapy via @DrewQJoseph"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948729221993435506) 2025-07-25 12:57:06 UTC 119.4K followers, 10.2K engagements "$SRPT Bloomberg story just published confirmed our reporting from yesterday"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948131463850807473) 2025-07-23 21:21:50 UTC 119.4K followers, 20.3K engagements "$SRPT just announced pause to all Elevidys shipments in the US"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947442773977927816) 2025-07-21 23:45:13 UTC 119.4K followers, 46.7K engagements "BREAKING: In surprise reversal Sarepta $SRPT says it will pause shipments of Duchenne gene therapy via @Jasonmmast and me"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947453283095703860) 2025-07-22 00:26:59 UTC 119.4K followers, 24.6K engagements "This week's Biotech Scorecard digs deeper into the Sarepta $SRPT #Duchenne gene therapy debacle. X. Sarepta may not survive. If Elevidys cannot return to the market (and STAT's reporting this week suggests it will not) the company is facing a severe cash flow and debt crisis. I dig deeper into the numbers. X. Putting business and stock prices aside this week has been wrenching for Duchenne families. On this week's Readout LOUD podcast we spoke with the mother of a boy who was treated with Elevidys. She wants Sarepta and the FDA to reach an agreement that returns Elevidys to the market. Listen"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948361331830067249) 2025-07-24 12:35:14 UTC 119.4K followers, 24.9K engagements "More $SRPT news: FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following X Deaths Sarepta refused"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946346984152973317) 2025-07-18 23:10:57 UTC 119.3K followers, 40.4K engagements "Sanofi $SNY to buy vaccine biotech Vicebio for $1.15B upfront via @DrewQJoseph"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947599400416498024) 2025-07-22 10:07:36 UTC 119.4K followers, 18.8K engagements "This is a story my colleague @Jasonmmast was chasing as well. A third patient death from liver failure caused by $SRPT gene therapy confirmed. The patient had limb-girdle disease. Sarepta knew about the death yesterday when it announced the restructuring and layoffs did not disclose"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946015579971739926) 2025-07-18 01:14:04 UTC 119.4K followers, 43.1K engagements "Psychedelic therapy from $ATAI and Beckley Psytech shows promise in mid-stage study in treatment-resistant depression via @megkesh"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1939989193985335739) 2025-07-01 10:07:21 UTC 119.4K followers, 15.5K engagements "CONFIRMED: FDA to request Sarepta Therapeutics $SRPT halt shipments of Duchenne gene therapy"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946260914505646144) 2025-07-18 17:28:56 UTC 119.4K followers, 20.4K engagements "Needless to say the last XX hours have been stunning for $SRPT. Shocking. Frustrating. Aggravating. Maddening. The fallout will impact gene therapy and all of biotech"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946263332555473165) 2025-07-18 17:38:32 UTC 119.3K followers, 78.4K engagements "$SRPT After firing XXX employees cutting programs and decimating the stock price all after two wheelchair-bound boys died bc of Elevidys. CEO Doug Ingram keeps his job Ian Estepan promoted to President / COO with a salary bump to $800K Louise Rodino-Klapac promoted to President Research and Development and Technical Operations with a salary bump to $800K Ryan Wong promoted to CFO with a salary bump"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1945582246574133338) 2025-07-16 20:32:09 UTC 119.4K followers, 30K engagements "BioX in total might be dimmed these days but there are some individuals on this platform sharing fantastic and profitable investment ideas. BIG hat tip to @A_May_MD @Biohazard3737 @seedy19tron for an amazing call on $ABVX and anyone else who contributed to this. Wow"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947951808753602905) 2025-07-23 09:27:57 UTC 119.4K followers, 8313 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@adamfeuerstein
"$XLRN This (below) is what Behzad said about Immunomedics before he took control and got it sold to Gilead" @adamfeuerstein on X 2021-09-30 19:56:56 UTC 119.4K followers, XX engagements
"The podcast interview I mentioned earlier: A mothers perspective on Sareptas $SRPT gene therapy halt via @statnews" @adamfeuerstein on X 2025-07-24 16:17:13 UTC 119.4K followers, 18.1K engagements
"STAT's @matthewherper talks with $MRK CEO Rob Davis about the $11B $XLRN deal and the pharma giant's "post Keytruda" strategy" @adamfeuerstein on X 2021-09-30 15:58:29 UTC 119.4K followers, XX engagements
"$SRPT The death referred to in the FDA statement may be the boy from Brazil who was disclosed earlier today by Brazilian authorities. Details in that announcement were scant but the timing of that death and age described in the FDA statement fit what STAT had learned about that case. Will let you know if I confirm" @adamfeuerstein on X 2025-07-25 21:56:33 UTC 119.4K followers, 19.2K engagements
"Drugmakers are racing to help patients stay awake and could also make billions A great read from my colleague @elaineywchen reporting on the development of orexin inhibitors $ALKS $CNTA $TAK Link below" @adamfeuerstein on X 2025-07-22 12:19:29 UTC 119.4K followers, 9224 engagements
"NEW: Sarepta Therapeutics $SRPT crisis is huge blow to Duchenne families company Our attempt to put the past 20-ish insane hours into perspective. via @Jasonmmast and me" @adamfeuerstein on X 2025-07-18 20:31:39 UTC 119.4K followers, 13.8K engagements
"$NTLA clinical update: 8K This new Liver tox. In addition enrollment in our global Phase X MAGNITUDE study of nex-z for ATTR-CM is progressing according to our expectations. Currently we have enrolled approximately XXX patients in the MAGNITUDE study out of an expected total enrollment of approximately XXX patients and anticipate enrollment completion by early 2027. Over two hundred patients have been dosed with nex-z in the MAGNITUDE study. To date reported adverse events have been similar in nature to the reported adverse events in the Phase X study of nex-z for ATTR amyloidosis and have" @adamfeuerstein on X 2025-05-28 20:48:06 UTC 119.4K followers, 40.4K engagements
"George Tidmarsh named new CDER chief per Bloomberg" @adamfeuerstein on X 2025-07-21 10:42:10 UTC 119.4K followers, 12.5K engagements
"Just in the past week Takeda announced that two late-stage trials succeeded and Alkermes disclosed its mid-stage study was positive saying that its therapy helped patients reach normal levels of wakefulness. Along with Centessa Pharmaceuticals the drugmakers are also testing orexin candidates in narcolepsy type X and idiopathic hypersomnia other sleep conditions that the drugs have shown early potential to treat. In these three rare sleep disorders alone analysts project a greater than $X billion market with potential to grow even bigger as more patients seek diagnoses and treatment" @adamfeuerstein on X 2025-07-22 12:19:30 UTC 119.4K followers, 5115 engagements
"$SRPT Its always my fault. Or the medias fault. 🙄 Well folks I didnt cause Sareptas clinical trials to fail. I didnt decide to approve Elevidys for a broad swath of DMD patients. I dont treat patients nor influence whether they benefit or not. Im not responsible for liver failure hospitalizations or deaths. I didnt set Sareptas material disclosure policy. The FDA didnt ask for my advice on whether to ask Sarepta to halt shipments and Sarepta didnt consult with me when it refused. I dont work for Sarepta. I dont work for the FDA. I have no financial ties to Sarepta. No financial disclosures" @adamfeuerstein on X 2025-07-20 17:45:36 UTC 119.4K followers, 61.1K engagements
"$SRPT FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys So sad" @adamfeuerstein on X 2025-07-25 21:39:41 UTC 119.4K followers, 45.1K engagements
"$SRPT CEO Doug Ingram concludes today's conference call by saying "We are a very transparent organization."" @adamfeuerstein on X 2025-07-18 15:16:53 UTC 119.3K followers, 25.8K engagements
"EXCLUSIVE: Sarepta Therapeutics $SRPT Duchenne therapy faces arduous path back to market senior FDA official says via @Jasonmmast and me" @adamfeuerstein on X 2025-07-22 18:35:13 UTC 119.4K followers, 49.2K engagements
"@Sanctuary_Bio @JacobPlieth @ApexOnco $COGT CEO leans too heavily into the $BPMC avi hate. Let the data speak for itself without the passive-aggressive insults. It's counterproductive" @adamfeuerstein on X 2025-07-07 18:55:24 UTC 119.4K followers, 2242 engagements
"$PFE bought a PD1xVEGF antibody from Chinas 3SBio. $1.25B upfront" @adamfeuerstein on X 2025-05-20 00:14:49 UTC 119.4K followers, 42.1K engagements
"$SRPT With Elevidys paused risk to balance sheet and solvency is an issue again. Obviously will depend on how long Elevidys remains off the market and whether Sarepta can restructure debt if necessary" @adamfeuerstein on X 2025-07-22 00:59:18 UTC 119.4K followers, 24.1K engagements
"$LLY acquires $ARMO for $1.6B to strengthen cancer immunotherapy pipeline As @bradloncar says It's a cytokine world" @adamfeuerstein on X 2018-05-10 12:13:20 UTC 119.4K followers, XX engagements
"What the f--k is this person talking about" @adamfeuerstein on X 2025-07-20 17:56:56 UTC 119.3K followers, 28.8K engagements
"Akeso and $SMMT Ivonescimab in Combination with Chemotherapy Demonstrates Statistically Significant and Strongly Positive Results in First-Line Treatment of Squamous Non-Small Cell Lung Cancer (sq-NSCLC) vs. Tislelizumab in Combination with Chemotherapy" @adamfeuerstein on X 2025-04-23 10:34:07 UTC 119.3K followers, 15.7K engagements
"Alkermes $ALKS drug helped narcolepsy patients stay awake in Phase X trial More orexin results but no numbers for now. via @elaineywchen" @adamfeuerstein on X 2025-07-21 10:09:56 UTC 119.3K followers, 9421 engagements
"Constellations myelofibrosis drug shows greater benefit easing concerns about its future #ASH20 $CNST $INCY" @adamfeuerstein on X 2020-12-06 18:15:26 UTC 119.4K followers, XX engagements
"Now official and then some. Sarepta Therapeutics $SRPT lays off one-third of workforce in drastic cost-cutting move w/ @Jasonmmast" @adamfeuerstein on X 2025-07-16 20:19:44 UTC 119.3K followers, 11K engagements
"Sarepta Therapeutics $SRPT the maker of a gene therapy for Duchenne muscular dystrophy that is being temporarily shelved because of safety concerns faces an arduous and treacherous path to try to get it back onto the market a senior official at the Food and Drug Administration told STAT suggesting the treatments license could be revoked" @adamfeuerstein on X 2025-07-22 18:35:55 UTC 119.4K followers, 16.8K engagements
"I'm just seeing this now but Joe Schwartz at Leerink is doing hero's work today on $SRPT" @adamfeuerstein on X 2025-07-19 00:33:33 UTC 119.4K followers, 35.7K engagements
"The crisis over Sareptas $SRPT Duchenne therapy is a mess. But the lesson is clear via @matthewherper" @adamfeuerstein on X 2025-07-21 18:41:32 UTC 119.4K followers, 9946 engagements
"UnitedHealth $UNH confirms DOJ investigations into Medicare practices says its cooperating via @TaraBannow" @adamfeuerstein on X 2025-07-24 14:13:56 UTC 119.4K followers, 7243 engagements
"UPDATED:. Sarepta Therapeutics $SRPT crisis is huge blow to Duchenne families company Company has refused FDA request that it pull gene therapy from the market following patient deaths" @adamfeuerstein on X 2025-07-18 23:54:45 UTC 119.4K followers, 48.5K engagements
"$CELG would have raised the $ARMO offer to $XX after KN-189" @adamfeuerstein on X 2018-05-23 13:14:38 UTC 119.4K followers, XX engagements
"I made another strawberry rhubarb pie today will be sharing with a friend once it cools down" @adamfeuerstein on X 2025-07-25 20:46:20 UTC 119.4K followers, 8070 engagements
"$SRPT More confirmation here from @Jared_Whitlock of what we heard. The patient death occurred one month ago. Let that sink in when you think back to yesterday" @adamfeuerstein on X 2025-07-18 01:32:45 UTC 119.4K followers, 49.6K engagements
"Why did $SRPT reverse course Sarepta says this "proactive" step will give it time to confer with FDA and remove Elevidys from its regulatory limbo (meaning hopefully keeping the drug on the market for ambulatory patients.) But Sarepta was also forced into this reversal bc hospitals were pausing use of Elevidys out of caution and safety/liability concerns STAT learned" @adamfeuerstein on X 2025-07-22 00:31:41 UTC 119.3K followers, 8985 engagements
"$SRPT FDA will request Sarepta Therapeutics voluntarily stop all shipments of Elevidys - Reuters citing a source familiar with the matter Stock halted" @adamfeuerstein on X 2025-07-18 17:02:38 UTC 119.3K followers, 32.8K engagements
"Why Sarepta may not survive its current gene therapy crisis. Plus: Who gets to decide the CEOs fate" @adamfeuerstein on X 2025-07-24 12:35:15 UTC 119.4K followers, 6888 engagements
"Cogent Biosciences $COGT drug improves symptoms of chronic immune disorder study results show A comparison of the therapy to a rival treatment from Blueprint Medicines $BPMC remains muddled" @adamfeuerstein on X 2025-07-07 14:59:13 UTC 119.4K followers, 10.4K engagements
"Merck $MRK to buy lung-disease biotech Verona Pharma $VRNA for $XX billion -- $XXX / share XX% premium -- Deal centerpiece: Verona's Ohtuvayre a treatment for chronic obstructive pulmonary disease. Blockbuster in the making. -- Merck needs to replace the expected loss of revenue when blockbuster cancer drug Keytruda loses patent protection. -- 2nd largest M&A transaction this year. -- Pharma has appetite for commercial-stage companies: Verona Intra-Cellular Blueprint" @adamfeuerstein on X 2025-07-09 11:24:11 UTC 119.4K followers, 19.2K engagements
"Small biotech Abivax $ABVX scores major win with ulcerative colitis trials Stock trading +400% to $XX this morning. Incredible via @DrewQJoseph" @adamfeuerstein on X 2025-07-23 09:24:04 UTC 119.4K followers, 12.9K engagements
"Regenerons Yancopoulos is still bitter over Praluent sales. Can Novartis do better $REGN $NVS $MDCO #JPM20" @adamfeuerstein on X 2020-01-15 16:21:14 UTC 119.3K followers, XX engagements
"$SRPT Fully updated story w/ Brazil Japan suspensions Elevidys patient death in Brazil said to be due to influenza Europe moves to reject embattled Duchenne muscular dystrophy gene therapy via @DrewQJoseph" @adamfeuerstein on X 2025-07-25 12:57:06 UTC 119.4K followers, 10.2K engagements
"$SRPT Bloomberg story just published confirmed our reporting from yesterday" @adamfeuerstein on X 2025-07-23 21:21:50 UTC 119.4K followers, 20.3K engagements
"$SRPT just announced pause to all Elevidys shipments in the US" @adamfeuerstein on X 2025-07-21 23:45:13 UTC 119.4K followers, 46.7K engagements
"BREAKING: In surprise reversal Sarepta $SRPT says it will pause shipments of Duchenne gene therapy via @Jasonmmast and me" @adamfeuerstein on X 2025-07-22 00:26:59 UTC 119.4K followers, 24.6K engagements
"This week's Biotech Scorecard digs deeper into the Sarepta $SRPT #Duchenne gene therapy debacle. X. Sarepta may not survive. If Elevidys cannot return to the market (and STAT's reporting this week suggests it will not) the company is facing a severe cash flow and debt crisis. I dig deeper into the numbers. X. Putting business and stock prices aside this week has been wrenching for Duchenne families. On this week's Readout LOUD podcast we spoke with the mother of a boy who was treated with Elevidys. She wants Sarepta and the FDA to reach an agreement that returns Elevidys to the market. Listen" @adamfeuerstein on X 2025-07-24 12:35:14 UTC 119.4K followers, 24.9K engagements
"More $SRPT news: FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following X Deaths Sarepta refused" @adamfeuerstein on X 2025-07-18 23:10:57 UTC 119.3K followers, 40.4K engagements
"Sanofi $SNY to buy vaccine biotech Vicebio for $1.15B upfront via @DrewQJoseph" @adamfeuerstein on X 2025-07-22 10:07:36 UTC 119.4K followers, 18.8K engagements
"This is a story my colleague @Jasonmmast was chasing as well. A third patient death from liver failure caused by $SRPT gene therapy confirmed. The patient had limb-girdle disease. Sarepta knew about the death yesterday when it announced the restructuring and layoffs did not disclose" @adamfeuerstein on X 2025-07-18 01:14:04 UTC 119.4K followers, 43.1K engagements
"Psychedelic therapy from $ATAI and Beckley Psytech shows promise in mid-stage study in treatment-resistant depression via @megkesh" @adamfeuerstein on X 2025-07-01 10:07:21 UTC 119.4K followers, 15.5K engagements
"CONFIRMED: FDA to request Sarepta Therapeutics $SRPT halt shipments of Duchenne gene therapy" @adamfeuerstein on X 2025-07-18 17:28:56 UTC 119.4K followers, 20.4K engagements
"Needless to say the last XX hours have been stunning for $SRPT. Shocking. Frustrating. Aggravating. Maddening. The fallout will impact gene therapy and all of biotech" @adamfeuerstein on X 2025-07-18 17:38:32 UTC 119.3K followers, 78.4K engagements
"$SRPT After firing XXX employees cutting programs and decimating the stock price all after two wheelchair-bound boys died bc of Elevidys. CEO Doug Ingram keeps his job Ian Estepan promoted to President / COO with a salary bump to $800K Louise Rodino-Klapac promoted to President Research and Development and Technical Operations with a salary bump to $800K Ryan Wong promoted to CFO with a salary bump" @adamfeuerstein on X 2025-07-16 20:32:09 UTC 119.4K followers, 30K engagements
"BioX in total might be dimmed these days but there are some individuals on this platform sharing fantastic and profitable investment ideas. BIG hat tip to @A_May_MD @Biohazard3737 @seedy19tron for an amazing call on $ABVX and anyone else who contributed to this. Wow" @adamfeuerstein on X 2025-07-23 09:27:57 UTC 119.4K followers, 8313 engagements
/creator/twitter::102094857/posts